HEADER HYDROLASE 08-JUN-20 6ZBM TITLE STRUCTURE OF THE D125N MUTANT OF THE CATALYTIC DOMAIN OF THE BACILLUS TITLE 2 CIRCULANS ALPHA-1,6 MANNANASE IN COMPLEX WITH AN ALPHA-1,6-ALPHA- TITLE 3 MANNO-CYCLOPHELLITOL CARBASUGAR-STABILISED TRISACCHARIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-1,6-MANNANASE; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES; COMPND 6 OTHER_DETAILS: CATALYTIC DOMAIN OF BCGH76 WITHOUT SIGNAL PEPTIDE AND COMPND 7 WITH N-TERMINAL HIS TAG, AND WITH MUTATIONS D125N AND R341Q SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS CIRCULANS; SOURCE 3 ORGANISM_TAXID: 1397; SOURCE 4 GENE: AMAN6; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ENDO-ALPHA-1, 6-MANNANASE, EPOXIDE, INHIBITOR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR G.J.DAVIES,W.A.OFFEN REVDAT 5 24-JAN-24 6ZBM 1 REMARK REVDAT 4 14-JUL-21 6ZBM 1 JRNL REVDAT 3 02-JUN-21 6ZBM 1 JRNL REVDAT 2 05-MAY-21 6ZBM 1 JRNL REVDAT 1 28-APR-21 6ZBM 0 JRNL AUTH S.P.SCHRODER,W.A.OFFEN,A.MALES,Y.JIN,C.DE BOER,J.ENOTARPI, JRNL AUTH 2 L.MARINO,G.A.VAN DER MAREL,B.I.FLOREA,J.D.C.CODEE, JRNL AUTH 3 H.S.OVERKLEEFT,G.J.DAVIES JRNL TITL DEVELOPMENT OF NON-HYDROLYSABLE OLIGOSACCHARIDE JRNL TITL 2 ACTIVITY-BASED INACTIVATORS FOR ENDOGLYCANASES: A CASE STUDY JRNL TITL 3 ON ALPHA-1,6 MANNANASES. JRNL REF CHEMISTRY V. 27 9519 2021 JRNL REFN ISSN 0947-6539 JRNL PMID 33878235 JRNL DOI 10.1002/CHEM.202101255 REMARK 2 REMARK 2 RESOLUTION. 1.47 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0258 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.47 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.66 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 44764 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.162 REMARK 3 R VALUE (WORKING SET) : 0.159 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 2304 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.47 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.51 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3284 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.45 REMARK 3 BIN R VALUE (WORKING SET) : 0.3260 REMARK 3 BIN FREE R VALUE SET COUNT : 162 REMARK 3 BIN FREE R VALUE : 0.4750 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2625 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 178 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.88 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.43000 REMARK 3 B22 (A**2) : 0.31000 REMARK 3 B33 (A**2) : -1.14000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.30000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.094 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.083 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.081 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.101 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.965 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2815 ; 0.012 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2374 ; 0.003 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3838 ; 1.722 ; 1.651 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5527 ; 1.632 ; 1.599 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 344 ; 6.156 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 154 ;36.858 ;24.481 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 421 ;13.359 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 7 ;23.188 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 364 ; 0.093 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3211 ; 0.011 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 618 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 5188 ; 4.620 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS U VALUES : REMARK 3 REFINED INDIVIDUALLY REMARK 3 THERE ARE REGIONS OF UNMODELLED DENSITY NEAR THE SIDE CHAINS OF REMARK 3 ASN206, HIS340 AND TYR360. REMARK 4 REMARK 4 6ZBM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-JUN-20. REMARK 100 THE DEPOSITION ID IS D_1292108704. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-JAN-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 47092 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.470 REMARK 200 RESOLUTION RANGE LOW (A) : 66.120 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 3.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.47 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.50 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 4D4A.PDB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 28.43 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.72 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, AMMONIUM NITRATE, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.06050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 530 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12860 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 14 REMARK 465 GLY A 15 REMARK 465 SER A 16 REMARK 465 SER A 17 REMARK 465 HIS A 18 REMARK 465 HIS A 19 REMARK 465 HIS A 20 REMARK 465 HIS A 21 REMARK 465 HIS A 22 REMARK 465 HIS A 23 REMARK 465 SER A 24 REMARK 465 SER A 25 REMARK 465 GLY A 26 REMARK 465 LEU A 27 REMARK 465 GLU A 28 REMARK 465 VAL A 29 REMARK 465 LEU A 30 REMARK 465 PHE A 31 REMARK 465 GLN A 32 REMARK 465 GLY A 33 REMARK 465 PRO A 34 REMARK 465 ALA A 35 REMARK 465 TYR A 36 REMARK 465 THR A 37 REMARK 465 ALA A 38 REMARK 465 GLY A 353 REMARK 465 GLN A 354 REMARK 465 LEU A 355 REMARK 465 LEU A 356 REMARK 465 SER A 357 REMARK 465 GLY A 358 REMARK 465 ILE A 375 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 65 CE NZ REMARK 470 LYS A 68 CE NZ REMARK 470 LYS A 99 CE NZ REMARK 470 LYS A 112 NZ REMARK 470 GLU A 147 CG CD OE1 OE2 REMARK 470 GLU A 164 CD OE1 OE2 REMARK 470 GLU A 233 CG CD OE1 OE2 REMARK 470 LYS A 257 CE NZ REMARK 470 LYS A 311 CE NZ REMARK 470 GLU A 321 CG CD OE1 OE2 REMARK 470 GLU A 325 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 238 49.07 -88.37 REMARK 500 LEU A 279 44.60 -93.92 REMARK 500 REMARK 500 REMARK: NULL DBREF 6ZBM A 35 375 UNP Q9Z4P9 Q9Z4P9_BACCI 35 375 SEQADV 6ZBM MET A 14 UNP Q9Z4P9 INITIATING METHIONINE SEQADV 6ZBM GLY A 15 UNP Q9Z4P9 EXPRESSION TAG SEQADV 6ZBM SER A 16 UNP Q9Z4P9 EXPRESSION TAG SEQADV 6ZBM SER A 17 UNP Q9Z4P9 EXPRESSION TAG SEQADV 6ZBM HIS A 18 UNP Q9Z4P9 EXPRESSION TAG SEQADV 6ZBM HIS A 19 UNP Q9Z4P9 EXPRESSION TAG SEQADV 6ZBM HIS A 20 UNP Q9Z4P9 EXPRESSION TAG SEQADV 6ZBM HIS A 21 UNP Q9Z4P9 EXPRESSION TAG SEQADV 6ZBM HIS A 22 UNP Q9Z4P9 EXPRESSION TAG SEQADV 6ZBM HIS A 23 UNP Q9Z4P9 EXPRESSION TAG SEQADV 6ZBM SER A 24 UNP Q9Z4P9 EXPRESSION TAG SEQADV 6ZBM SER A 25 UNP Q9Z4P9 EXPRESSION TAG SEQADV 6ZBM GLY A 26 UNP Q9Z4P9 EXPRESSION TAG SEQADV 6ZBM LEU A 27 UNP Q9Z4P9 EXPRESSION TAG SEQADV 6ZBM GLU A 28 UNP Q9Z4P9 EXPRESSION TAG SEQADV 6ZBM VAL A 29 UNP Q9Z4P9 EXPRESSION TAG SEQADV 6ZBM LEU A 30 UNP Q9Z4P9 EXPRESSION TAG SEQADV 6ZBM PHE A 31 UNP Q9Z4P9 EXPRESSION TAG SEQADV 6ZBM GLN A 32 UNP Q9Z4P9 EXPRESSION TAG SEQADV 6ZBM GLY A 33 UNP Q9Z4P9 EXPRESSION TAG SEQADV 6ZBM PRO A 34 UNP Q9Z4P9 EXPRESSION TAG SEQADV 6ZBM ASN A 125 UNP Q9Z4P9 ASP 125 ENGINEERED MUTATION SEQADV 6ZBM GLN A 341 UNP Q9Z4P9 ARG 341 ENGINEERED MUTATION SEQRES 1 A 362 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 362 LEU GLU VAL LEU PHE GLN GLY PRO ALA TYR THR ALA SER SEQRES 3 A 362 ASP GLY ASP THR ALA MET LYS ALA PHE ASN ASP THR PHE SEQRES 4 A 362 TRP ASP PRO ASN ALA LYS MET PHE TRP LYS ASP SER LYS SEQRES 5 A 362 ARG GLU LYS HIS GLN ASP PHE TRP VAL GLU ALA GLU LEU SEQRES 6 A 362 TRP GLU LEU VAL MET ASP ALA TYR GLN HIS THR SER ASP SEQRES 7 A 362 PRO ALA LEU LYS ALA GLU LEU LYS THR GLN ILE ASP ASP SEQRES 8 A 362 VAL TYR ASP GLY THR VAL ALA LYS TYR GLY GLN ASP TRP SEQRES 9 A 362 THR ASN ASN PRO PHE ASN ASP ASN ILE MET TRP TRP ALA SEQRES 10 A 362 MET GLY SER ALA ARG ALA TYR GLN ILE THR GLY ASN PRO SEQRES 11 A 362 ARG TYR LEU GLU ALA ALA ARG ASP HIS PHE ASP PHE VAL SEQRES 12 A 362 TYR ASP THR GLN TRP ASP GLU GLU PHE ALA ASN GLY GLY SEQRES 13 A 362 ILE TRP TRP LEU ASN SER ASP HIS ASN THR LYS ASN ALA SEQRES 14 A 362 CYS ILE ASN PHE PRO ALA ALA GLN ALA ALA LEU TYR LEU SEQRES 15 A 362 TYR ASP ILE THR LYS ASP GLU HIS TYR LEU ASN ALA ALA SEQRES 16 A 362 THR LYS ILE PHE ARG TRP GLY LYS THR MET LEU THR ASP SEQRES 17 A 362 GLY ASN GLY LYS VAL PHE ASP ARG ILE GLU ILE GLU HIS SEQRES 18 A 362 GLY ALA VAL PRO ASP ALA THR HIS TYR ASN GLN GLY THR SEQRES 19 A 362 TYR ILE GLY SER ALA VAL GLY LEU TYR LYS ALA THR GLY SEQRES 20 A 362 ASN ALA VAL TYR LEU ASP ASP ALA VAL LYS ALA ALA LYS SEQRES 21 A 362 PHE THR LYS ASN HIS LEU VAL ASP SER ASN GLY VAL LEU SEQRES 22 A 362 ASN TYR GLU GLY PRO ASN GLY ASP LEU LYS GLY GLY LYS SEQRES 23 A 362 THR ILE LEU MET ARG ASN LEU ALA HIS LEU GLN LYS THR SEQRES 24 A 362 LEU ASP GLU THR GLY GLN TYR PRO GLU PHE SER ALA GLU SEQRES 25 A 362 PHE ASP GLU TRP LEU ALA PHE ASN ILE GLU MET ALA TRP SEQRES 26 A 362 SER HIS GLN ASN SER ASP HIS ILE VAL ASP GLY ASN TRP SEQRES 27 A 362 ALA GLY GLN LEU LEU SER GLY THR TYR GLU SER TRP SER SEQRES 28 A 362 SER ALA ALA ALA VAL GLN ALA LEU ASN GLY ILE HET EDO A 401 4 HET EDO A 402 4 HET QE8 A 403 23 HET MAN A 404 11 HETNAM EDO 1,2-ETHANEDIOL HETNAM QE8 (1~{R},2~{R},3~{R},4~{S},5~{R})-4-[[(1~{S},2~{S},3~{S}, HETNAM 2 QE8 4~{R},5~{R})-5-(HYDROXYMETHYL)-2,3,4-TRIS(OXIDANYL) HETNAM 3 QE8 CYCLOHEXYL]OXYMETHYL]CYCLOHEXANE-1,2,3,5-TETROL HETNAM MAN ALPHA-D-MANNOPYRANOSE HETSYN EDO ETHYLENE GLYCOL HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 2 EDO 2(C2 H6 O2) FORMUL 4 QE8 C14 H26 O9 FORMUL 5 MAN C6 H12 O6 FORMUL 6 HOH *178(H2 O) HELIX 1 AA1 SER A 39 PHE A 52 1 14 HELIX 2 AA2 ASP A 71 THR A 89 1 19 HELIX 3 AA3 ASP A 91 GLY A 114 1 24 HELIX 4 AA4 PHE A 122 GLY A 141 1 20 HELIX 5 AA5 ASN A 142 TRP A 161 1 20 HELIX 6 AA6 ALA A 182 LYS A 200 1 19 HELIX 7 AA7 ASP A 201 THR A 220 1 20 HELIX 8 AA8 THR A 241 GLY A 260 1 20 HELIX 9 AA9 ASN A 261 LEU A 279 1 19 HELIX 10 AB1 GLY A 297 GLY A 317 1 21 HELIX 11 AB2 TYR A 319 HIS A 340 1 22 HELIX 12 AB3 GLU A 361 LEU A 372 1 12 SHEET 1 AA1 2 TRP A 53 ASP A 54 0 SHEET 2 AA1 2 MET A 59 PHE A 60 -1 O MET A 59 N ASP A 54 SHEET 1 AA2 2 THR A 179 ASN A 181 0 SHEET 2 AA2 2 ARG A 229 GLU A 231 -1 O ILE A 230 N LYS A 180 LINK OD2 ASP A 124 C1 QE8 A 403 1555 1555 1.44 LINK O61 QE8 A 403 C1 MAN A 404 1555 1555 1.35 CISPEP 1 GLY A 290 PRO A 291 0 1.49 CRYST1 43.768 66.121 49.397 90.00 100.23 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022848 0.000000 0.004124 0.00000 SCALE2 0.000000 0.015124 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020571 0.00000